Two weekly vinorelbine: administration in patients who have received at least two prior chemotherapy regimes for advanced breast cancer.
- 1 January 2000
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 36 (2) , 177-182
- https://doi.org/10.1016/s0959-8049(99)00219-1
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Salvage Chemotherapy With Paclitaxel, Vinorelbine, and Cisplatin (PVC) in Anthracycline-Resistant Advanced Breast CancerAmerican Journal of Clinical Oncology, 1998
- Combined effect of navelbine with medroxyprogesterone acetate against human breast carcinoma MCF-7 cells in vitro.British Journal of Cancer, 1998
- Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.Journal of Clinical Oncology, 1997
- Phase II study of vinorelbine and ifosfamide in anthtracycline resistent metastatic breast cancerBreast Cancer Research and Treatment, 1997
- Vinorelbine: An active, non cross-resistant drug in advanced breast cancer. Results from a phase II studyBreast Cancer Research and Treatment, 1996
- Multicenter phase II study of weekly oral vinorelbine for stage IV non-small-cell lung cancer.Journal of Clinical Oncology, 1995
- Vinorelbine (Navelbine) as a salvage treatment for advanced breast cancerAnnals of Oncology, 1994
- Reporting results of cancer treatmentCancer, 1981